Has the frequency of ABO RhD blood groups in Australian blood donors changed as a result of the removal of the variant Creutzfeldt–Jakob disease‐based deferral?
Vox Sanguinis · 2024
DOI: 10.1111/vox.13614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2024. Verfasst von Rena Hirani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Australian Red Cross Lifeblood, Sydney, Australia. Hauptthemen laut MEDLINE: Blood Donors, ABO Blood-Group System, Creutzfeldt-Jakob Syndrome, Rh-Hr Blood-Group System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Governments fund Australian Red Cross Lifeblood to provide blood, blood products and services to the Australian community, Australian Government.
Abstract (Originalsprache)
Background and Objectives Until 25 July 2022, Australians who had spent more than 6 months in the United Kingdom or territories between 1980 and 1996 were deferred from blood donation due to the risk of variant Creutzfeldt–Jakob disease. Removal of this geography‐based donor deferral on RhD‐negative blood availability has not been reported. Materials and Methods All donors who donated at least once from 25 July 2022 to 25 July 2023 were included. UK donor status, first‐time donor and ABO RhD data were extracted from the National Blood Management System.
Results
Data from 566,447 blood donors with a valid ABO RhD result were analysed. Of these, 34,560 were new or returning lapsed donors following removal of the UK donor deferral. The median age [range] in years for all donors was 43 [75] with UK donors being older 53 [70]. There was a higher prevalence of RhD‐negative status in UK donors (20.2%) compared with first‐time blood donors (15.7%).
Conclusion
UK donors were generally older, female and more likely to be RhD‐negative. Although UK donors provided a boost to RhD‐negative blood collections, the overall prevalence of ABO RhD blood groups in the total Australian blood donor panel remained similar to previous estimates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Australian Red Cross Lifeblood, Sydney, Australia.
- School of Natural Sciences, Macquarie University, Sydney, Australia.
- Australian Red Cross Lifeblood, Perth, Australia.
- School of Medicine, Western Sydney University, Sydney, Australia.
- Faculty of Health, University of Technology, Sydney, Australia.
ORCID-Profile: Rena Hirani, Veronica C Hoad
Förderung
- Australian Governments fund Australian Red Cross Lifeblood to provide blood, blood products and services to the Australian community
- Australian Government
Zitieren
APA
Hirani, R., Hoad, V. C., Gosbell, I. B., & Irving, D. O. (2024). Has the frequency of ABO RhD blood groups in Australian blood donors changed as a result of the removal of the variant Creutzfeldt–Jakob disease‐based deferral?. Vox Sanguinis. https://doi.org/10.1111/vox.13614
Vancouver
Hirani R, Hoad VC, Gosbell IB, Irving DO. Has the frequency of ABO RhD blood groups in Australian blood donors changed as a result of the removal of the variant Creutzfeldt–Jakob disease‐based deferral?. Vox Sanguinis. 2024. doi:10.1111/vox.13614
BibTeX
@article{Hirani2024,
author = {Hirani, Rena and Hoad, Veronica C and Gosbell, Iain B and Irving, David O},
title = {Has the frequency of ABO RhD blood groups in Australian blood donors changed as a result of the removal of the variant Creutzfeldt–Jakob disease‐based deferral?},
journal = {Vox Sanguinis},
year = {2024},
doi = {10.1111/vox.13614}
}
EUVIMED